Live birth rate per woman · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes live birth rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Ongoing pregnancy · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes ongoing pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes clinical pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in multiple pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (moderate certainty).
1 finding from 1 review
Miscarriage · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in miscarriage rate per woman compared with day 2 embryo transfer following IVF or ICSI (moderate certainty).
1 finding from 1 review
Complications during pregnancy per woman per couple ‐ ectopic pregnancy4 · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in ectopic pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (low certainty).
1 finding from 1 review
Ongoing pregnancy / live birth rate per woman · women undergoing pituitary suppression in assisted reproduction
GnRHa depot showed no clear difference in live birth/ongoing pregnancy rate per woman Delivery of one or more… compared with gnRHa daily injection (low certainty).
1 finding from 1 review
Number of days of gonadotrophin treatment ‐ half dose · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review
Number of days of gonadotrophin treatment ‐ full dose · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review
Clinical pregnancy rate · women undergoing pituitary suppression in assisted reproduction
GnRHa depot showed no clear difference in clinical pregnancy rate per woman Identified by the presence of a… compared with gnRHa daily injection (moderate certainty).
1 finding from 1 review
OHSS · women undergoing pituitary suppression in assisted reproduction
GnRHa depot showed no clear difference in OHSS incidence rates compared with gnRHa daily injection (low certainty).
1 finding from 1 review
Miscarriage · women undergoing pituitary suppression in assisted reproduction
GnRHa depot showed no clear difference in miscarriage rates compared with gnRHa daily injection (low certainty).
1 finding from 1 review
Number of oocytes retrieved · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review
Multiple pregnancy rate · women undergoing pituitary suppression in assisted reproduction
GnRHa depot showed no clear difference in multiple pregnancy rates compared with gnRHa daily injection (low certainty).
1 finding from 1 review
Number of gonadotropin (FSH) units employed · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review
Number of gonadotrophin (FSH) units employed ‐ half dose · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review
Number of gonadotrophin (FSH) units employed ‐ full dose · women undergoing pituitary suppression in assisted reproduction
1 finding from 1 review
Live birth or ongoing pregnancy · Women undergoing IVF/ICSI cycles
ORT‐based algorithm showed no clear difference in live birth or ongoing pregnancy compared with standard starting dose of FSH (low certainty).
1 finding from 1 review
IU vs 150 IU · women undergoing IVF/ICSI who are anticipated to have a normal response to stimulation based on at least one ORT measure
1 finding from 1 review
IU vs 100 IU · women undergoing IVF/ICSI who are anticipated to have a hyper‐response to stimulation based on at least one ORT measure
Anticipated high responders: higher showed no clear difference in IU vs 100 IU compared with lower dose of FSH (low certainty).
1 finding from 1 review